SCHEMBL21362601

SCHEMBL21362601

O=Cc1ccc(SCl)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.41
LMNA P02545 3/20 0.38
TDP1 Q9NUW8 2/20 0.36
ERN1 O75460 4/20 0.36
TRIM24 O15164 1/20 0.34
TRIM33 Q9UPN9 1/20 0.34
ALDH1A1 P00352 2/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TERT O14746 1/20 0.31
MEN1 O00255 1/20 0.31
THRB P10828 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP2A6 P11509 3/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776519 0.80 ALDH1A1 (0.47) PRKDCLMNAERN1TRIM24TRIM33
SCHEMBL2279052 0.78 TDP1 (0.44) PRKDCLMNATDP1ERN1ALDH1A1
SCHEMBL12375092 0.77 TERT (0.43) PRKDCLMNATDP1ERN1ALDH1A1
SCHEMBL20607737 0.76 PRKDC (0.42) PRKDCLMNAERN1TRIM24TRIM33
SCHEMBL16706976 0.76 LMNA (0.46) PRKDCLMNATDP1ERN1ALDH1A1
SCHEMBL3253021 0.74 TERT (0.45) LMNATDP1ERN1ALDH1A1MAPT
SCHEMBL20535669 0.73 LMNA (0.43) PRKDCLMNATDP1ERN1ALDH1A1
SCHEMBL380731 0.72 TDP1 (0.61) PRKDCLMNATDP1ERN1TRIM24
SCHEMBL20535344 0.72 LMNA (0.53) LMNATDP1ALDH1A1MAPTHPGD
SCHEMBL6094668 0.72 ERN1 (0.57) LMNATDP1ERN1TRIM24TRIM33

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed